• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHZ2400278 马来酸奈拉替尼片 neratinib maleate Tablet Chemical Drugs(5.1) License Renew 2024-10-15 view
CYHS2402776 马来酸奈拉替尼片 neratinib maleate Tablet Chemical Drugs(4) Generic Drug 2024-08-26 view
JYHB2400373 马来酸奈拉替尼片 neratinib maleate Tablet Chemical Drugs(5.1) Supplementary Application 2024-07-18 view
CXHL2400045 马来酸奈拉替尼片 neratinib maleate Tablet Chemical Drugs(2.4) New Drug Application 2024-01-10 view
JYHB2300697 马来酸奈拉替尼片 neratinib maleate Tablet Chemical Drugs(5.1) Supplementary Application 2023-12-07 view
JYHB2300563 马来酸奈拉替尼片 neratinib maleate Tablet Chemical Drugs(5.1) Supplementary Application 2023-09-29 view
CXHL2300934 马来酸奈拉替尼片 neratinib maleate Tablet Chemical Drugs(2.4) New Drug Application 2023-09-01 view
CXHL2300363 马来酸奈拉替尼片 neratinib maleate Tablet Chemical Drugs(2.4) New Drug Application 2023-04-12 Fukang (Shanghai) Health Technology Co Ltd view
CYHS2300221 马来酸奈拉替尼片 neratinib maleate Tablet Chemical Drugs(4) Generic Drug 2023-01-28 Hunan Kelun Pharmaceutical Co Ltd view
CYHS2202095 马来酸奈拉替尼片 neratinib maleate Tablet Chemical Drugs(4) Generic Drug 2022-12-24 view
CYHS2202006 马来酸奈拉替尼片 neratinib maleate Tablet Chemical Drugs(4) Generic Drug 2022-11-17 Jiangsu Aosaikang Pharmaceutical Co Ltd view
JYHB2200298 马来酸奈拉替尼片 neratinib maleate Tablet Chemical Drugs(5.1) Supplementary Application 2022-06-16 view
CYHS2200120 马来酸奈拉替尼片 neratinib maleate Tablet Chemical Drugs(4) Generic Drug 2022-01-19 Shanghai Acebright Pharmaceuticals Co Ltd view